During the period 1962-71 a total of 2544 patients with respiratory sarcoidosis were reported to the Danish Institute of Clinical Epidemiology. Among them 48 patients developed a malignant tumour, the follow-up period ending on 31 December 1971. Only 33·8 cases of cancer were expected if sarcoidosis patients had had the same rates as the general population; the difference between the expected and observed number is statistically significant (0·02 > P > 0·01). Malignant lymphomata occurred 11 times and lung cancer 3 times more frequently than expected. For all other forms of cancer taken together, there was no significant difference between the expected and the observed number of cases.

The increased cancer incidence may result from immunological deficiencies in patients with sarcoidosis.

• Endobronchial ultrasound-guided transbronchial needle aspiration facilitating diagnosis of sarcoidosis in a breast cancer patient with multiple lymphadenopathy: a case report

  • Yuka Oride
  • Yumiko Koi
  • Shingo Kawamura

  Journal of Medical Case Reports (2022)

• Clinical Characteristics of Sarcoidosis Patients with Self-Reported Lymphoma: A US Nationwide Registry Study

  • Bashar N. Alzghoul
  • Yazan Zayed
  • Divya C. Patel

  Lung (2021)

• Challenges in the management of life-threatening complications caused by a rare case of sarcoid-lymphoma syndrome

  • Stephanie S. Taha-Mehlitz
  • Irin I. Zschokke
  • Lana L. Fourie

  International Journal of Colorectal Disease (2020)

• Hilar and mediastinal sarcoid-like reaction after the treatment of malignant tumors: imaging features and natural course on 18F-FDG-PET/CT

  • Yo Kaneko
  • Hiroki Kato
  • Masayuki Matsuo

  Japanese Journal of Radiology (2019)

• Increased prevalence of prior malignancies and autoimmune diseases in patients diagnosed with chronic myeloid leukemia

  • N Gunnarsson
  • M Höglund
  • A Själander

  Leukemia (2016)